ES2052640T3 - Procedimiento para la obtencion de oxazolidinonas. - Google Patents

Procedimiento para la obtencion de oxazolidinonas.

Info

Publication number
ES2052640T3
ES2052640T3 ES88110754T ES88110754T ES2052640T3 ES 2052640 T3 ES2052640 T3 ES 2052640T3 ES 88110754 T ES88110754 T ES 88110754T ES 88110754 T ES88110754 T ES 88110754T ES 2052640 T3 ES2052640 T3 ES 2052640T3
Authority
ES
Spain
Prior art keywords
alcoil
atomos
alcohil
habitually
usually
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88110754T
Other languages
English (en)
Inventor
Helmut Prucher
Henning Dr Bottcher
Rudolf Dr Gottschlich
Klaus-Otto Dr Minck
Anton Dr Haase
Christoph Dr Seyfried
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Application granted granted Critical
Publication of ES2052640T3 publication Critical patent/ES2052640T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/36—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

NUEVA OXAZOLIDINA DE LA FORMULA I DONDE R1 Y R2 SIGNIFICAN RESIDUOS DE HETEROARILOS, QUE CONTIENEN 1 - 4 HETEROATOMOS DE UNO O DE DOS NUCLEOS, HABITUALMENTE NO SUSTITUIDOS O UNA O DOS VECES A TRAVES DE ALCOHIL, ALCOXI, ALCOHILTIO, ALCOHILSULFENILO O ALCOHILSULFONILO CON HABITUALMENTE 1 - 4 - C ATOMOS, ALCANOILOXI Y / O ALCANOILAMINO CON HABITUALMENTE 1 - 6 - C - ATOMOS, F, CL, BR, OH Y / O CF3 SUSTITUIDOS POR FENILO - BENCILO, R3 Y R4 SIGNIFICAN HABITUALMENTE H, ALCOHIL O ALCOXI CON HABITUALMENTE 1 - 4 - C ATOMOS F, CL, BR, OH O CF3, ASI COMO SUS SALES MUESTRAN EFECTOS SOBRE EL SISTEMA CENTRAL DE LOS NERVIOS, ESPECIALMENTE EFECTOS NEUROLEPTICOS.
ES88110754T 1987-07-18 1988-07-06 Procedimiento para la obtencion de oxazolidinonas. Expired - Lifetime ES2052640T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873723797 DE3723797A1 (de) 1987-07-18 1987-07-18 Oxazolidinone

Publications (1)

Publication Number Publication Date
ES2052640T3 true ES2052640T3 (es) 1994-07-16

Family

ID=6331852

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88110754T Expired - Lifetime ES2052640T3 (es) 1987-07-18 1988-07-06 Procedimiento para la obtencion de oxazolidinonas.

Country Status (10)

Country Link
US (1) US4970217A (es)
EP (1) EP0300272B1 (es)
JP (1) JPH01163177A (es)
KR (1) KR890002060A (es)
AT (1) ATE80627T1 (es)
AU (1) AU616185B2 (es)
DE (2) DE3723797A1 (es)
ES (1) ES2052640T3 (es)
HU (1) HUT50813A (es)
ZA (1) ZA885189B (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4005371A1 (de) * 1990-02-21 1991-08-22 Merck Patent Gmbh Oxazolidinone
AU618177B2 (en) * 1990-03-27 1991-12-12 Biomin Technologies Sa Biological oxidation of sulfide ore
US5066663A (en) * 1990-05-21 1991-11-19 Warner-Lambert Company Substituted-hetero-cyclopentanones and cyclopentenones and derivatives thereof acting at muscarinic receptors
DE4017211A1 (de) * 1990-05-29 1991-12-05 Merck Patent Gmbh Oxazolidinone
EP0623615B1 (de) * 1993-05-01 1999-06-30 MERCK PATENT GmbH Substituierte 1-Phenyl-oxazolidin-2-on Derivate, deren Herstellung und deren Verwendung als Adhäsionsrezeptor-Antagonisten
DE4324393A1 (de) * 1993-07-21 1995-01-26 Merck Patent Gmbh 4-Aryloxy- und 4-Arylthiopiperidinderivate
DE4332384A1 (de) * 1993-09-23 1995-03-30 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten III
DE4425613A1 (de) * 1994-07-20 1996-01-25 Bayer Ag 5-gliedrige Heteroaryl-oxazolidinone
DE4425612A1 (de) * 1994-07-20 1996-04-04 Bayer Ag 6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone
US5691323A (en) * 1995-05-12 1997-11-25 Merck & Co., Inc. Muscarine antagonists
DE4439846A1 (de) * 1994-11-08 1996-05-09 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten
DE19504954A1 (de) * 1995-02-15 1996-08-22 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten
HRP960159A2 (en) * 1995-04-21 1997-08-31 Bayer Ag Benzocyclopentane oxazolidinones containing heteroatoms
DE19531321A1 (de) * 1995-08-25 1997-02-27 Merck Patent Gmbh Piperidinylmethyloxazolidinone
DE19707628A1 (de) * 1997-02-26 1998-08-27 Merck Patent Gmbh Oxazolidinone
DE19739332C1 (de) * 1997-09-09 1998-11-26 Merck Patent Gmbh Piperidinylmethyloxazolidinon-Derivat
BR9815348A (pt) * 1997-12-04 2000-10-17 Sankyo Co " composto, uso deste ou de um sal farmacologicamente aceitável, éster ou outro derivado do mesmo, medicamento, agentes preventivos ou terapêuticos para asma e/ou bronquite, para rinite, para doença alérgica, e para incontinência urinária, e, processos de prevenção ou tratamento de asma e/ou bronquite, de rinite, de doença alérgica, e de incontinência urinária. "
MXPA02002749A (es) 2001-03-27 2002-10-28 Warner Lambert Co Derivados de ciclohexilamina como antagonistas del subtipo selectivo del n-metil-d-aspartato.
US7141588B2 (en) * 2002-02-25 2006-11-28 Pfizer, Inc. N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
WO2008021309A1 (en) * 2006-08-15 2008-02-21 Wyeth Imidazolidin-2-one derivatives useful as pr modulators
WO2008021337A1 (en) 2006-08-15 2008-02-21 Wyeth Oxazinan-2-one derivatives useful as pr modulators
US7649007B2 (en) * 2006-08-15 2010-01-19 Wyeth Llc Oxazolidine derivatives as PR modulators
TW200815428A (en) 2006-08-15 2008-04-01 Wyeth Corp Oxazolidone derivatives as PR modulators
CL2008001002A1 (es) 2007-04-11 2008-10-17 Actelion Pharmaceuticals Ltd Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
CN103570640A (zh) * 2012-07-30 2014-02-12 华东师范大学 一种由二氧化碳一锅法直接制备噁唑烷-2-酮类化合物的方法
CN104341369A (zh) * 2013-08-01 2015-02-11 华东师范大学 噁唑烷-2-酮类化合物的制备方法
EP3541793B1 (de) 2016-11-09 2021-03-31 Covestro Intellectual Property GmbH & Co. KG Verfahren zur herstellung von triaryl-organoboraten
US11242360B2 (en) 2016-11-09 2022-02-08 Covestro Deutschland Ag Process for the manufacturing of triaryl-organo borates
US11078218B2 (en) 2016-11-09 2021-08-03 Covestro Deutschland Ag Process for the production of triaryl organoborates

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL129025C (es) * 1965-04-29
GB1222708A (en) * 1968-10-22 1971-02-17 Delalande Sa Novel 5-(n-substituted aminomethyl)-2-oxazolidinones and their process of preparation
DE2060816C3 (de) 1970-12-10 1980-09-04 Merck Patent Gmbh, 6100 Darmstadt 4-Phenylpiperidinderivate Verfahren zu ihrer Herstellung und pharmazeutische Zubereitungen enthaltend diese Verbindungen
US3856962A (en) * 1973-07-10 1974-12-24 R Alphin Anti-inflammatory agents
US4082755A (en) * 1977-02-14 1978-04-04 Janssen Pharmaceutica N.V. 1-[(Diarylmethyl)aminoalkyl]piperidimes
FR2500450A1 (fr) * 1981-02-25 1982-08-27 Delalande Sa Nouveaux derives aminomethyl-5 oxazolidiniques, leur procede de preparation et leur application en therapeutique
AU607735B2 (en) * 1987-05-07 1991-03-14 A.H. Robins Company, Incorporated Novel cyclic carbamate derivatives

Also Published As

Publication number Publication date
DE3874642D1 (en) 1992-10-22
AU616185B2 (en) 1991-10-24
US4970217A (en) 1990-11-13
HUT50813A (en) 1990-03-28
EP0300272B1 (de) 1992-09-16
EP0300272A1 (de) 1989-01-25
AU1892688A (en) 1989-01-19
JPH01163177A (ja) 1989-06-27
ZA885189B (en) 1989-03-29
KR890002060A (ko) 1989-04-07
DE3723797A1 (de) 1989-01-26
ATE80627T1 (de) 1992-10-15

Similar Documents

Publication Publication Date Title
ES2052640T3 (es) Procedimiento para la obtencion de oxazolidinonas.
ECSP088149A (es) 3-acilaminobenzanilidas insecticidas
ES2188016T3 (es) Derivaqdo de benzamidoxima, productos intermedios y procedimiento para su obtencion y su empleo como fungicidas.
ES2056928T3 (es) Compuestos heterociclicos.
AR241244A1 (es) Metodo para la preparacion de carboxilatos y dicarboxilatos de piridina sustituidos.
ES2052675T3 (es) 3-(4-piperazinil-sustituido en 1)butil)-4-tiazolidinonas, un procedimiento para su preparacion y su uso como medicamentos.
ES2063153T3 (es) Amino-4 quinoleinas y naftiridinas, su procedimiento de preparacion y su aplicacion como medicamentos.
ES2078324T3 (es) Pteridina-4 (3h)-onas, procedimientos de preparacion y medicamentos que los contienen.
ES2052727T3 (es) Composicion herbicida.
SE8902814L (sv) Anjoniska triazinylamino-disazofoereningar
ES398289A1 (es) Procedimiento para la preparacion de nuevos derivados de i-soflavona.
ES2040215T3 (es) Procedimiento para preparar nuevos tiazoles y oxazoles sustituidos.
ES2095848T3 (es) Nuevos derivados de fosfolipidos y su utilizacion para la preparacion de medicamentos antiviricos.
ES2096396T3 (es) Procedimiento para la obtencion de polimeros, formados por alqu-1-enos con 2 a 10 atomos de carbono con empleo de complejos de metaloceno racemicos como catalizadores.
ES2063117T3 (es) Derivados del tieno(2,3-d)acepina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
SE7704616L (sv) Sett att framstella nya 11-desoxi-prostaglandin-fÿ2-derivat
SE8004319L (sv) Cefalosporinforeningar, sett for framstellning derav samt lekemedel innehallande dess foreningar
ES2080859T3 (es) Alfa-(alquilciclohexiloxi)-beta-alcanoles y composiciones de perfume que contienen los mismos.
ES2117132T3 (es) Sales de desferrioxamina-b y su uso como queladores de hierro eficaces por via oral.
ES2055138T3 (es) Procedimiento de preparacion de nuevos derivados del benceno.
ES2038708T3 (es) Metodo para producir compuestos de benzotiepino(5,4-c)piridazina.
AR241534A1 (es) Compuestos de 7-(2-(5-amino-1,2,4-tiazol-3-il)-2-alcoxiimino-acetamido)-3-metil-imidazo piridinio o imidazo-pirimidinio-3-cefem-4-carboxilato y sus sales.
CO4600746A1 (es) Uso de benzaldehidos para la marcacion de hidrocarburos
ES2041755T3 (es) Procedimiento para la preparacion de nuevas tiadiacinas, e insecticidas.
FI853685A0 (fi) Nya n-alk(en)yl-n-(o,o-disubstituerade -tiofosforyl)-n'n'-disubstituerade glycinamider, foerfarande foer framstaellning av dessa samt kvalstergifter, insektgifter och svampgifter vilka innehaoller dessa som aktiv bestaondsdel.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 300272

Country of ref document: ES